New York University School of Medicine

PureTech, Siddhartha Mukherjee launch Vor BioPharma

Wednesday, May 11, 2016

PureTech Health has launched Vor BioPharma, an immuno-oncology company dedicated to developing a new class of targeted cell therapies. The company, which is advancing a novel approach to chimeric antigen receptor (CAR) T-cell therapy, has licensed its core technology from the lab of Vor scientific co-founder, Siddhartha Mukherjee, M.D., Ph.D., assistant professor of Medicine at Columbia University and Pulitzer Prize-winning author of The Emperor of All Maladies: A Biography of Cancer.

[Read More]

U.S. research institutions collaborate to share, standardize neuroscience databases

Wednesday, August 13, 2014

The Allen Institute for Brain Science based in Seattle, Wash., the California Institute of Technology, the New York University School of Medicine, the Howard Hughes Medical Institute (HHMI) in Massachusetts and the University of California, Berkeley are collaborating on a project aimed at making databases about the brain more useable and accessible for neuroscientists—a step seen as critical to accelerating the pace of discoveries about the brain in health and disease.

[Read More]